These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 15367630)
21. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Glende J; Schwegmann-Wessels C; Al-Falah M; Pfefferle S; Qu X; Deng H; Drosten C; Naim HY; Herrler G Virology; 2008 Nov; 381(2):215-21. PubMed ID: 18814896 [TBL] [Abstract][Full Text] [Related]
22. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566 [TBL] [Abstract][Full Text] [Related]
23. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Jia HP; Look DC; Shi L; Hickey M; Pewe L; Netland J; Farzan M; Wohlford-Lenane C; Perlman S; McCray PB J Virol; 2005 Dec; 79(23):14614-21. PubMed ID: 16282461 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. Hou Y; Peng C; Yu M; Li Y; Han Z; Li F; Wang LF; Shi Z Arch Virol; 2010 Oct; 155(10):1563-9. PubMed ID: 20567988 [TBL] [Abstract][Full Text] [Related]
25. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. Li F J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527 [TBL] [Abstract][Full Text] [Related]
26. Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells. Fukushi S; Mizutani T; Sakai K; Saijo M; Taguchi F; Yokoyama M; Kurane I; Morikawa S J Virol; 2007 Oct; 81(19):10831-4. PubMed ID: 17652383 [TBL] [Abstract][Full Text] [Related]
27. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. Haga S; Nagata N; Okamura T; Yamamoto N; Sata T; Yamamoto N; Sasazuki T; Ishizaka Y Antiviral Res; 2010 Mar; 85(3):551-5. PubMed ID: 19995578 [TBL] [Abstract][Full Text] [Related]
28. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Hofmann H; Geier M; Marzi A; Krumbiegel M; Peipp M; Fey GH; Gramberg T; Pöhlmann S Biochem Biophys Res Commun; 2004 Jul; 319(4):1216-21. PubMed ID: 15194496 [TBL] [Abstract][Full Text] [Related]
29. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697 [TBL] [Abstract][Full Text] [Related]
30. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Wang H; Yang P; Liu K; Guo F; Zhang Y; Zhang G; Jiang C Cell Res; 2008 Feb; 18(2):290-301. PubMed ID: 18227861 [TBL] [Abstract][Full Text] [Related]
31. Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells. Hattori T; Saito T; Okuya K; Takahashi Y; Miyamoto H; Kajihara M; Igarashi M; Takada A Microbiol Spectr; 2022 Aug; 10(4):e0087022. PubMed ID: 35862965 [TBL] [Abstract][Full Text] [Related]
32. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936 [TBL] [Abstract][Full Text] [Related]
33. A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. Wong SK; Li W; Moore MJ; Choe H; Farzan M J Biol Chem; 2004 Jan; 279(5):3197-201. PubMed ID: 14670965 [TBL] [Abstract][Full Text] [Related]
34. Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors. Zhang Y; Zheng N; Nan P; Cao Y; Hasegawa M; Zhong Y Comput Biol Chem; 2007 Apr; 31(2):134-7. PubMed ID: 17368104 [TBL] [Abstract][Full Text] [Related]
35. Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. Fukushi S; Watanabe R; Taguchi F Methods Mol Biol; 2008; 454():331-8. PubMed ID: 19057867 [TBL] [Abstract][Full Text] [Related]
36. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion. Howard MW; Travanty EA; Jeffers SA; Smith MK; Wennier ST; Thackray LB; Holmes KV J Virol; 2008 Mar; 82(6):2883-94. PubMed ID: 18199653 [TBL] [Abstract][Full Text] [Related]
37. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. Ren W; Qu X; Li W; Han Z; Yu M; Zhou P; Zhang SY; Wang LF; Deng H; Shi Z J Virol; 2008 Feb; 82(4):1899-907. PubMed ID: 18077725 [TBL] [Abstract][Full Text] [Related]
38. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. Hofmann H; Hattermann K; Marzi A; Gramberg T; Geier M; Krumbiegel M; Kuate S; Uberla K; Niedrig M; Pöhlmann S J Virol; 2004 Jun; 78(12):6134-42. PubMed ID: 15163706 [TBL] [Abstract][Full Text] [Related]
39. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus. Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551 [TBL] [Abstract][Full Text] [Related]
40. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]